Nurses play a pivotal role in monitoring patients on dopamine-related medications. Regular assessment tools, like the Abnormal Involuntary Movement Scale (AIMS), can help detect early signs of EPS. Additionally, educating patients about potential side effects and encouraging them to report new symptoms promptly can aid in timely intervention.
